CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 1 filers reported holding CONCERT PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,893,300 | -12.8% | 666,661 | 0.0% | 0.56% | -17.4% |
| Q3 2022 | $4,467,000 | +110.2% | 666,661 | +32.1% | 0.68% | +102.7% |
| Q2 2022 | $2,125,000 | -9.2% | 504,661 | +267.8% | 0.34% | +53.0% |
| Q1 2017 | $2,340,000 | +106.7% | 137,212 | +24.7% | 0.22% | -1.4% |
| Q4 2016 | $1,132,000 | +12.0% | 110,000 | +10.0% | 0.22% | +20.0% |
| Q3 2016 | $1,011,000 | -10.0% | 100,000 | 0.0% | 0.18% | -22.9% |
| Q2 2016 | $1,123,000 | -17.8% | 100,000 | 0.0% | 0.24% | -16.4% |
| Q1 2016 | $1,366,000 | – | 100,000 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| L1 Capital Pty Ltd | 1,050,124 | $10,312,000 | 3.31% |
| Alambic Investment Management, L.P. | 19,934 | $196,000 | 2.15% |
| INGALLS & SNYDER LLC | 1,363,603 | $13,391,000 | 0.92% |
| ACUTA CAPITAL PARTNERS, LLC | 300,000 | $2,946,000 | 0.80% |
| RA Capital Management | 1,858,474 | $18,250,000 | 0.33% |
| Perceptive Advisors | 2,150,641 | $21,119,000 | 0.31% |
| SPHERA FUNDS MANAGEMENT LTD. | 310,000 | $3,044,000 | 0.30% |
| Eversept Partners, LP | 103,829 | $1,019,601 | 0.23% |
| Opaleye Management Inc. | 100,000 | $982,000 | 0.19% |
| GSA CAPITAL PARTNERS LLP | 58,095 | $570,000 | 0.10% |